Literature DB >> 3110680

Effect of haemodialysis on upper gastrointestinal tract pathology in patients with chronic renal failure.

A Chachati, J P Godon.   

Abstract

Upper gastrointestinal tract pathology observed at autopsy in 94 patients with end-stage renal disease (GFR less than 10 ml/min) was analysed retrospectively. To better evaluate the effect of haemodialysis on this pathology, the chronic renal failure patients were subdivided into three groups: 19 patients who had died before haemodialysis treatment could be undertaken (group I), 21 patients who had died during the first month (group II), and 54 patients who had died after at least one month of haemodialysis treatment (group III). The results revealed that the number of patients with upper gastrointestinal tract pathology was significantly higher in groups I and II (58% and 57% respectively) as compared to group III (31%) and controls (35%). No difference could be demonstrated between group III and controls. The most prevalent lesions observed were gastritis, followed by gastric and peptic ulcers. The incidence of this pathology appeared to decline as the duration of dialysis therapy increased. Mortality caused by upper gastrointestinal tract pathology remained high during the first two years of treatment in group III, despite a smaller incidence of upper tract lesions. This was explained by a relatively higher proportion of haemorrhage.

Entities:  

Mesh:

Year:  1987        PMID: 3110680

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Wireless capsule endoscopy in the investigation of patients with chronic renal failure and obscure gastrointestinal bleeding (preliminary data).

Authors:  Stephanos Karagiannis; Spyros Goulas; Georgios Kosmadakis; Petros Galanis; Dimitrios Arvanitis; John Boletis; Evangelos Georgiou; Christos Mavrogiannis
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

2.  Gastrointestinal symptoms: a comparison between patients undergoing peritoneal dialysis and hemodialysis.

Authors:  Rui Dong; Zhi-Yong Guo; Jia-Rong Ding; Yang-Yang Zhou; Hao Wu
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 3.  Anticoagulation in CKD and ESRD.

Authors:  Kelvin Cheuk-Wai Leung; Jennifer Marie MacRae
Journal:  J Nephrol       Date:  2019-01-28       Impact factor: 3.902

Review 4.  Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis.

Authors:  Jenny I Shen; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2012-05-05       Impact factor: 8.860

5.  The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trial.

Authors:  Davina J Tai; Kelvin Leung; Pietro Ravani; Robert R Quinn; Nairne Scott-Douglas; Jennifer M MacRae
Journal:  BMC Nephrol       Date:  2015-08-25       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.